Avantor (AVTR) Q1 2025 Results Reflects Focus on Cost Management
Avantor, Inc. (NYSE:AVTR) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. The company’s Q1 2025 results exhibited disciplined execution as well as a continued focus on cost management amidst the dynamic macro environment. Even though the company’s earnings and margin performance remained in line with its plan, the Lab […]